retatrutide parkinson clinical trial 💊 There's a new once-daily #Parkinsons #drug nearing FDA decision. @abbvie's Parkinson's research trial numbers remain

Many human RCTs included in this review (e.g., Kadouh et al., 2020

In addition to the well-known effects of GLP-1 and GLP-1 RA in improving insulin sensitivity and reducing body weight, at central levels, GLP-1 and GLP-1 RA might exert regulating effects on GhRH release, and on concomitant gonadotropin secretion, likely by activating the kisspeptin hypothalamic system, a key regulator of the pulsatile release of GnRH from GnRH neurons

An initial decline in eGFR is common after treatment initiation but typically stabilizes over time, contributing to long-term preservation of kidney function [108]

Metabolic monitoring is required

No refund, no exceptions

Rite Aid's compounded-peptide program shows that non-prescription or compounded peptides are sometimes sold through waitlist-based clinic offers